INSR and Alzheimer disease: Recent literature further suggests that the mechanisms for the association between T2D and high AD risk revolves around glucotoxicity, and its downstream consequences like insulin resistance, impaired insulin receptor signaling, advanced glycation end products, or inflammation [36, 37].